Peer-facilitated treatment access for hepatitis C: the Live Hep C Free project

被引:9
|
作者
Silano, Julia A. [1 ]
Treloar, Carla [2 ]
Leadbeatter, Kyle [3 ]
Davidson, Sandy [3 ]
Doidge, Justine [3 ]
机构
[1] McMaster Univ, Hamilton, ON, Canada
[2] Univ New South Wales, Sydney, NSW, Australia
[3] Hepatitis NSW, Sydney, NSW, Australia
关键词
Hepatitis C; Peer workers; Socially marginalised groups; Community-based HCV care; INJECT DRUGS; VIRUS; PEOPLE; CARE; ELIMINATION; AUSTRALIA; SERVICES; BARRIERS;
D O I
10.1186/s12954-022-00619-3
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background This commentary explores the lessons learned during implementation of a peer-facilitated hepatitis C virus (HCV) testing and treatment access project called the Live Hep C Free (LHCF) project in contributing to micro-elimination efforts. Case presentation The LHCF project aims to facilitate access to on-the-spot HCV testing, treatment, and care in priority settings through partnership between a peer worker (PW) and a clinical nurse. Since the start of the project in January 2018, 4515 people were engaged about HCV and encouraged to access on-site HCV health care, and over 1000 people were screened for HCV and liver health, while almost 250 people accessed HCV treatment through the project. This commentary is intended to prompt discussion about incorporating peer-centred HCV health programs into priority sites. HCV care-delivery models such as the LHCF project can continue to contribute to micro-elimination of HCV in key settings to increase treatment uptake amongst high prevalence and/or marginalised populations and support progress toward national elimination targets. Conclusions The LHCF project has been able to highlight the benefits of incorporating trustworthy, efficient, and convenient peer-centred health services to engage and support vulnerable populations through HCV testing and treatment, particularly individuals who have historically been disconnected from the health care system. Additional attention is needed to ensure ongoing funding support to sustain the project and deliver at scale and in expanding evaluation data to examine the operation and outcomes of the project in more detail.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Is the UK set to be hepatitis C free?
    Guerra-Veloz, Maria Fernanda
    Soliman, Riham
    Agarwal, Kosh
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (08) : 609 - 611
  • [42] Taribavirin in the treatment of hepatitis C
    Deming, Paulina
    Arora, Sanjeev
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (10) : 1435 - 1443
  • [43] Progress in hepatitis C treatment
    Vinaixa, Carmen
    Aguilera, Victoria
    Berenguer, Marina
    MEDICINA CLINICA, 2013, 141 (10): : 447 - 452
  • [44] Barriers to hepatitis C treatment
    McGowan, Christopher E.
    Fried, Michael W.
    LIVER INTERNATIONAL, 2012, 32 : 151 - 156
  • [45] Treatment of chronic hepatitis C
    Bihl, F.
    Negro, F.
    MINERVA MEDICA, 2009, 100 (06) : 459 - 465
  • [46] Hepatitis C treatment: interferon free or interferon freer?
    Dusheiko, Geoffrey
    Burney, Tabinda
    LANCET, 2013, 381 (9883): : 2063 - 2065
  • [47] Pathways to ensure universal and affordable access to hepatitis C treatment
    Caitlin H. Douglass
    Alisa Pedrana
    Jeffrey V. Lazarus
    Ellen F. M. ‘t Hoen
    Radi Hammad
    Ricardo Baptista Leite
    Andrew Hill
    Margaret Hellard
    BMC Medicine, 16
  • [48] Project ECHO: a Revolutionary Approach to Expanding Access to Modern Treatments for Hepatitis C
    Karla Thornton
    Paulina Deming
    Bruce Struminger
    Miranda Sedillo
    Eric Castillo
    Miriam Komaromy
    Sarah Zalud-Cerrato
    Sanjeev Arora
    Current Hepatology Reports, 2016, 15 (3) : 178 - 186
  • [49] A multi-level intervention to eliminate hepatitis C from the Region of Southern Denmark: the C-Free-South project
    Drose, Sandra
    Ovrehus, Anne Lindebo Holm
    Holm, Dorte Kinggaard
    Madsen, Lone Wulff
    Mossner, Belinda Klemmensen
    Soholm, Jacob
    Hansen, Janne Fuglsang
    Roge, Birgit Thorup
    Christensen, Peer Brehm
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [50] Predictors of treatment outcomes for Hepatitis C infection in a nationwide elimination program in Iceland: The treatment as prevention for Hepatitis C (TraP HepC) study
    Olafsson, Sigurdur
    Love, Thorvardur Jon
    Fridriksdottir, Ragnheidur Hulda
    Tyrfingsson, Thorarinn
    Runarsdottir, Valgerdur
    Hansdottir, Ingunn
    Bergmann, Ottar Mar
    Bjornsson, Einar Stefan
    Johannsson, Birgir
    Sigurdardottir, Bryndis
    Love, Arthur
    Baldvinsdottir, Guorun Erna
    Thordardottir, Marianna
    Hernandez, Ubaldo Benitez
    Heimisdottir, Maria
    Hellard, Margaret
    Gottfredsson, Magnus
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2024, 133